← Back to headlines
Plus Therapeutics Beats Q4 EPS and Revenue Estimates
Plus Therapeutics reported a GAAP EPS of -$0.29, beating estimates by $0.01, and revenue of $5.21 million, surpassing expectations by $0.14 million.
12 Mar, 20:53 — 12 Mar, 20:53
Sources
Showing 1 of 1 sources
